Your browser doesn't support javascript.
loading
IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity.
Das Gupta, Dennis; Paul, Christoph; Samel, Nadine; Bieringer, Maria; Staudenraus, Daniel; Marini, Federico; Raifer, Hartmann; Menke, Lisa; Hansal, Lea; Camara, Bärbel; Roth, Edith; Daum, Patrick; Wanzel, Michael; Mernberger, Marco; Nist, Andrea; Bauer, Uta-Maria; Helmprobst, Frederik; Buchholz, Malte; Roth, Katrin; Bastian, Lorenz; Hartmann, Alina M; Baldus, Claudia; Ikuta, Koichi; Neubauer, Andreas; Burchert, Andreas; Jäck, Hans-Martin; Klein, Matthias; Bopp, Tobias; Stiewe, Thorsten; Pagenstecher, Axel; Lohoff, Michael.
Afiliação
  • Das Gupta D; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Paul C; University Hospital Gießen and Marburg, Dept. of Ophthalmology, Philipps University Marburg, Marburg, Germany.
  • Samel N; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Bieringer M; MVZ for Laboratory Medicine and Microbiology, Koblenz-Mittelrhein, Germany.
  • Staudenraus D; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Marini F; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Raifer H; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Menke L; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Hansal L; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Camara B; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Roth E; Institute for med. Microbiology & Hospital Hygiene, Philipps University Marburg, Marburg, Germany.
  • Daum P; Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Wanzel M; Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Mernberger M; Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
  • Nist A; Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
  • Bauer UM; Genomics Core Facility, Philipps University Marburg, Marburg, Germany.
  • Helmprobst F; Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
  • Buchholz M; Institute for Molecular Biology and Tumor Research (IMT), Center for Tumor- and Immunobiology (ZTI), Philipps University Marburg, Marburg, Germany.
  • Roth K; Core Facility for Mouse Pathology and Electron Microscopy, Philipps University Marburg, Marburg, Germany.
  • Bastian L; University Hospital Gießen and Marburg, and Philipps University, Institute of Neuropathology, Marburg, Germany.
  • Hartmann AM; University Hospital Gießen and Marburg, and Philipps University, Clinic for Gastroenterology and Core Facility Small Animal Ultrasound, Marburg, Germany.
  • Baldus C; Core facility for Cellular Imaging, Philipps University Marburg, Marburg, Germany.
  • Ikuta K; Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.
  • Neubauer A; Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.
  • Burchert A; Medical Department II, Hematology and Oncology, University Medical Center Schleswig- Holstein, Kiel, Germany.
  • Jäck HM; Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Klein M; University Hospital Gießen and Marburg, and Philipps University, Dept. Hematology, Oncology and Immunology, Marburg, Germany.
  • Bopp T; University Hospital Gießen and Marburg, and Philipps University, Dept. Hematology, Oncology and Immunology, Marburg, Germany.
  • Stiewe T; Division of Molecular Immunology, Nikolaus-Fiebiger Center, University of Erlangen-Nürnberg, Erlangen, Germany.
  • Pagenstecher A; Institute for Immunology, Research Center for Immunotherapy (FZI), University Cancer Center, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Lohoff M; Institute for Immunology, Research Center for Immunotherapy (FZI), University Cancer Center, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Cell Death Differ ; 29(11): 2163-2176, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35459909
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adult / Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha